- Home
- FUN vs ALVO Comparison
FUN vs ALVO Comparison
Compare FUN & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUN
- ALVO
- Stock Information
- Founded
- FUN 1983
- ALVO 2013
- Country
- FUN United States
- ALVO Luxembourg
- Employees
- FUN N/A
- ALVO N/A
- Industry
- FUN Services-Misc. Amusement & Recreation
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- FUN Consumer Discretionary
- ALVO Health Care
- Exchange
- FUN Nasdaq
- ALVO Nasdaq
- Market Cap
- FUN 4.6B
- ALVO 4.0B
- IPO Year
- FUN 1987
- ALVO N/A
- Fundamental
- Price
- FUN $45.36
- ALVO $13.36
- Analyst Decision
- FUN Strong Buy
- ALVO Buy
- Analyst Count
- FUN 14
- ALVO 1
- Target Price
- FUN $56.21
- ALVO $18.00
- AVG Volume (30 Days)
- FUN 1.1M
- ALVO 184.6K
- Earning Date
- FUN 02-27-2025
- ALVO 11-13-2024
- Dividend Yield
- FUN 1.34%
- ALVO N/A
- EPS Growth
- FUN N/A
- ALVO N/A
- EPS
- FUN 0.37
- ALVO N/A
- Revenue
- FUN $2,392,739,000.00
- ALVO $393,919,000.00
- Revenue This Year
- FUN $84.97
- ALVO $398.12
- Revenue Next Year
- FUN $3.85
- ALVO $44.73
- P/E Ratio
- FUN $123.52
- ALVO N/A
- Revenue Growth
- FUN 33.41
- ALVO 517.92
- 52 Week Low
- FUN $35.93
- ALVO $9.15
- 52 Week High
- FUN $58.70
- ALVO $18.00
- Technical
- Relative Strength Index (RSI)
- FUN 43.66
- ALVO 64.20
- Support Level
- FUN $44.50
- ALVO $13.06
- Resistance Level
- FUN $45.89
- ALVO $13.50
- Average True Range (ATR)
- FUN 1.63
- ALVO 0.37
- MACD
- FUN -0.45
- ALVO -0.00
- Stochastic Oscillator
- FUN 29.33
- ALVO 69.09
About FUN Cedar Fair L.P.
Six Flags Entertainment Corp is North America's regional amusement-resort operator with 27 amusement parks, 15 water parks and nine resort properties across 17 states in the U.S., Canada and Mexico. Six Flags provides coasters, themed rides, thrilling water parks, resorts and a portfolio of beloved intellectual property such as Looney Tunes, DC Comics and PEANUTS.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.